(Q46844591)

25 December 2017

title

Evaluation of gliclazide ability to attenuate the hyperglycaemic 'memory' induced by high glucose in isolated human endothelial cells (English)

1 reference

25 December 2017

0 references

1 reference

1 reference

4

1 reference

25 December 2017

author name string

Maddalena Corgnali

series ordinal

1

1 reference

25 December 2017

Ludovica Piconi

series ordinal

2

1 reference

25 December 2017

Michael Ihnat

series ordinal

3

1 reference

25 December 2017

publication date

1 May 2008

1 reference

25 December 2017

Diabetes - Metabolism: Research and Reviews

published in

1 reference

25 December 2017

volume

24

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

301-309

1 reference

25 December 2017

Biochemistry and molecular cell biology of diabetic complications

cites work

1 reference

7 January 2021

Increased expression of basement membrane components in human endothelial cells cultured in high glucose

1 reference

7 January 2021

Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling

1 reference

7 January 2021

Effects of gliclazide on platelet reactivity and free radicals in type II diabetic patients: Clinical assessment

1 reference

7 January 2021

Gliclazide decreases cell-mediated low-density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL

1 reference

7 January 2021

Free radical scavenging activity of sulfonylureas: a clinical assessment of the effect of gliclazide

1 reference

7 January 2021

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

1 reference

7 January 2021

Free radicals in diabetic endothelial cell dysfunction

1 reference

7 January 2021

Role of oxidative stress in development of complications in diabetes

1 reference

7 January 2021

Oxidative stress and diabetic vascular complications

1 reference

7 January 2021

Effects of gliclazide beyond metabolic control

1 reference

7 January 2021

High Glucose Induces Antioxidant Enzymes in Human Endothelial Cells in Culture: Evidence Linking Hyperglycemia and Oxidative Stress

1 reference

7 January 2021

Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation

1 reference

7 January 2021

Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells

1 reference

7 January 2021

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

1 reference

7 January 2021

High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells

1 reference

7 January 2021

Protein kinase C activation and the development of diabetic complications

1 reference

7 January 2021

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

7 January 2021

Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment

1 reference

7 January 2021

Gliclazide improves anti-oxidant status and nitric oxide-mediated vasodilation in Type 2 diabetes.

1 reference

7 January 2021

Gliclazide protects pancreatic beta-cells from damage by hydrogen peroxide

1 reference

7 January 2021

In vitro and in vivo antioxidant properties of gliclazide.

1 reference

7 January 2021

Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).

1 reference

7 January 2021

Hypothesis: the 'metabolic memory', the new challenge of diabetes

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.804

1 reference

25 December 2017

1 reference

25 December 2017